The atherectomy devices market size has grown strongly in recent years. It will grow from $1.01 billion in 2025 to $1.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing prevalence of peripheral artery disease, growing clinical adoption of minimally invasive debulking procedures, rise in hospital-based coronary intervention volumes, early introduction of rotational atherectomy technologies, expansion of vascular specialty centers.
The atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for advanced plaque modification tools, increasing use of atherectomy in complex calcified lesions, growing investments in next-generation device design and materials, expansion of outpatient and ambulatory vascular procedures, increasing adoption of image-guided endovascular therapies. Major trends in the forecast period include increasing adoption of atherectomy devices as a minimally invasive alternative for plaque removal in pad and cad cases, rising demand for specialized atherectomy systems tailored for peripheral, coronary, and neurovascular interventions, growing clinical preference for precision plaque debulking to improve vessel patency and reduce restenosis risk, increasing utilization of atherectomy in combination with angioplasty and stenting for complex arterial lesions, expanding development of multi-technology atherectomy portfolios including rotational, orbital, directional, and laser systems.
The increasing prevalence of coronary artery disease is expected to drive the growth of the atherectomy devices market in the coming years. Coronary artery disease (CAD) is a condition marked by the narrowing or obstruction of coronary arteries caused by plaque accumulation, which restricts blood flow to the heart. The rising occurrence of CAD is attributed to factors such as a growing elderly population worldwide, increased sedentary lifestyles, higher stress and mental health challenges, and greater consumption of unhealthy diets. Directional coronary atherectomy is a minimally invasive procedure used to remove arterial blockages, improving blood flow to the heart muscle and relieving chest pain. For example, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, deaths from cardiovascular disease increased to 8,311 in 2023 compared with 2022, while deaths related to atherosclerosis accounted for 60% of all cardiovascular fatalities in 2023, up from 59% in 2022. Therefore, the rising prevalence of coronary artery disease is fueling the growth of the atherectomy devices market.
Major companies in the atherectomy devices market are developing innovative products, such as atherectomy peripheral platform-based catheters, to gain a competitive advantage. These catheters are used to treat peripheral artery disease by navigating through blood vessels to address arterial blockages in the legs. For example, in October 2023, Cardio Flow, a US-based medical device manufacturer, launched the FreedomFlow, an orbital atherectomy peripheral platform. The FreedomFlow platform uses a modern mechanism to remove plaque blockages in the leg arteries, employing a proprietary catheter-based design that utilizes angular momentum physics. This design features a spiral geometry with five diamond-coated spheres that maintain constant contact with the vessel wall during both advancement and retraction.
In April 2023, Abbott Laboratories, a US-based medical device manufacturer, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition bolsters Abbott's vascular portfolio, enhancing its ability to provide care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc., also based in the US, specializes in producing innovative atherectomy systems.
Major companies operating in the atherectomy devices market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cardiovascular Systems Inc, Terumo Corporation, Avinger Inc, Straub Medical AG, AngioDynamics Inc, Rex Medical LP, Ra Medical Systems Inc, Koninklijke Philips NV, Shockwave Medical Inc, Merit Medical Systems Inc, iVascular SLU, Hawk Medical Technologies, Medinol Ltd, Cardionovum GmbH, Wellinq Medical Products, Veryan Medical, Penumbra Inc.
North America was the largest region in the atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the atherectomy devices market by increasing import costs for precision metal components, drive systems, micro-catheters, and laser modules used in rotational, orbital, and directional atherectomy systems, leading to higher procurement and procedure costs for hospitals and ambulatory care facilities. Segments most affected include coronary and peripheral atherectomy devices in regions that rely heavily on cross-border manufacturing and component sourcing, particularly across Asia-Pacific and Europe. However, tariffs are also encouraging local assembly, supplier diversification, and domestic production initiatives, which may support regional innovation and strengthen supply-chain resilience over time.
The atherectomy devices market research report is one of a series of new reports that provides atherectomy devices market statistics, including atherectomy devices industry global market size, regional shares, competitors with a atherectomy devices market share, detailed atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the atherectomy devices industry. This atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Atherectomy devices are specialized medical tools employed in atherectomy procedures, a minimally invasive surgery designed to eliminate atherosclerotic plaque from blood vessels. These devices are essential for treating arterial blockages, providing an accurate and minimally invasive method to restore blood flow and relieve symptoms related to peripheral artery disease (PAD) and coronary artery disease (CAD).
The primary types of atherectomy devices include rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and other related products. Rotational atherectomy devices are specialized tools designed to treat hardened, calcified plaques in arteries. These devices are used in various applications, including peripheral vascular, cardiovascular, and neurovascular applications. The end users encompass hospitals and surgical centers, ambulatory care centers, and other facilities.
The atherectomy devices market consists of sales of laser atherectomy devices, hydrodynamic atherectomy devices, and ultrasonic atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for advanced plaque modification tools, increasing use of atherectomy in complex calcified lesions, growing investments in next-generation device design and materials, expansion of outpatient and ambulatory vascular procedures, increasing adoption of image-guided endovascular therapies. Major trends in the forecast period include increasing adoption of atherectomy devices as a minimally invasive alternative for plaque removal in pad and cad cases, rising demand for specialized atherectomy systems tailored for peripheral, coronary, and neurovascular interventions, growing clinical preference for precision plaque debulking to improve vessel patency and reduce restenosis risk, increasing utilization of atherectomy in combination with angioplasty and stenting for complex arterial lesions, expanding development of multi-technology atherectomy portfolios including rotational, orbital, directional, and laser systems.
The increasing prevalence of coronary artery disease is expected to drive the growth of the atherectomy devices market in the coming years. Coronary artery disease (CAD) is a condition marked by the narrowing or obstruction of coronary arteries caused by plaque accumulation, which restricts blood flow to the heart. The rising occurrence of CAD is attributed to factors such as a growing elderly population worldwide, increased sedentary lifestyles, higher stress and mental health challenges, and greater consumption of unhealthy diets. Directional coronary atherectomy is a minimally invasive procedure used to remove arterial blockages, improving blood flow to the heart muscle and relieving chest pain. For example, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, deaths from cardiovascular disease increased to 8,311 in 2023 compared with 2022, while deaths related to atherosclerosis accounted for 60% of all cardiovascular fatalities in 2023, up from 59% in 2022. Therefore, the rising prevalence of coronary artery disease is fueling the growth of the atherectomy devices market.
Major companies in the atherectomy devices market are developing innovative products, such as atherectomy peripheral platform-based catheters, to gain a competitive advantage. These catheters are used to treat peripheral artery disease by navigating through blood vessels to address arterial blockages in the legs. For example, in October 2023, Cardio Flow, a US-based medical device manufacturer, launched the FreedomFlow, an orbital atherectomy peripheral platform. The FreedomFlow platform uses a modern mechanism to remove plaque blockages in the leg arteries, employing a proprietary catheter-based design that utilizes angular momentum physics. This design features a spiral geometry with five diamond-coated spheres that maintain constant contact with the vessel wall during both advancement and retraction.
In April 2023, Abbott Laboratories, a US-based medical device manufacturer, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition bolsters Abbott's vascular portfolio, enhancing its ability to provide care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc., also based in the US, specializes in producing innovative atherectomy systems.
Major companies operating in the atherectomy devices market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cardiovascular Systems Inc, Terumo Corporation, Avinger Inc, Straub Medical AG, AngioDynamics Inc, Rex Medical LP, Ra Medical Systems Inc, Koninklijke Philips NV, Shockwave Medical Inc, Merit Medical Systems Inc, iVascular SLU, Hawk Medical Technologies, Medinol Ltd, Cardionovum GmbH, Wellinq Medical Products, Veryan Medical, Penumbra Inc.
North America was the largest region in the atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the atherectomy devices market by increasing import costs for precision metal components, drive systems, micro-catheters, and laser modules used in rotational, orbital, and directional atherectomy systems, leading to higher procurement and procedure costs for hospitals and ambulatory care facilities. Segments most affected include coronary and peripheral atherectomy devices in regions that rely heavily on cross-border manufacturing and component sourcing, particularly across Asia-Pacific and Europe. However, tariffs are also encouraging local assembly, supplier diversification, and domestic production initiatives, which may support regional innovation and strengthen supply-chain resilience over time.
The atherectomy devices market research report is one of a series of new reports that provides atherectomy devices market statistics, including atherectomy devices industry global market size, regional shares, competitors with a atherectomy devices market share, detailed atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the atherectomy devices industry. This atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Atherectomy devices are specialized medical tools employed in atherectomy procedures, a minimally invasive surgery designed to eliminate atherosclerotic plaque from blood vessels. These devices are essential for treating arterial blockages, providing an accurate and minimally invasive method to restore blood flow and relieve symptoms related to peripheral artery disease (PAD) and coronary artery disease (CAD).
The primary types of atherectomy devices include rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and other related products. Rotational atherectomy devices are specialized tools designed to treat hardened, calcified plaques in arteries. These devices are used in various applications, including peripheral vascular, cardiovascular, and neurovascular applications. The end users encompass hospitals and surgical centers, ambulatory care centers, and other facilities.
The atherectomy devices market consists of sales of laser atherectomy devices, hydrodynamic atherectomy devices, and ultrasonic atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Atherectomy Devices Market Characteristics
3. Atherectomy Devices Market Supply Chain Analysis
4. Global Atherectomy Devices Market Trends and Strategies
5. Atherectomy Devices Market Analysis of End Use Industries
7. Global Atherectomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Atherectomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Atherectomy Devices Market Segmentation
10. Atherectomy Devices Market Regional and Country Analysis
11. Asia-Pacific Atherectomy Devices Market
12. China Atherectomy Devices Market
13. India Atherectomy Devices Market
14. Japan Atherectomy Devices Market
15. Australia Atherectomy Devices Market
16. Indonesia Atherectomy Devices Market
17. South Korea Atherectomy Devices Market
18. Taiwan Atherectomy Devices Market
19. South East Asia Atherectomy Devices Market
20. Western Europe Atherectomy Devices Market
21. UK Atherectomy Devices Market
22. Germany Atherectomy Devices Market
23. France Atherectomy Devices Market
24. Italy Atherectomy Devices Market
25. Spain Atherectomy Devices Market
26. Eastern Europe Atherectomy Devices Market
27. Russia Atherectomy Devices Market
28. North America Atherectomy Devices Market
29. USA Atherectomy Devices Market
30. Canada Atherectomy Devices Market
31. South America Atherectomy Devices Market
32. Brazil Atherectomy Devices Market
33. Middle East Atherectomy Devices Market
34. Africa Atherectomy Devices Market
36. Atherectomy Devices Market Competitive Landscape and Company Profiles
37. Atherectomy Devices Market Other Major and Innovative Companies
40. Atherectomy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Atherectomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for atherectomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atherectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Rotational Atherectomy Devices; Orbital Atherectomy Devices; Directional Atherectomy Devices; Other Products2) By Application: Peripheral Vascular Applications; Cardiovascular Applications; Neurovascular Applications
3) By End User: Hospitals And Surgical Centers; Ambulatory Care Centers; Other End Users
Subsegments:
1) By Rotational Atherectomy Devices: Coronary Rotational Atherectomy Devices; Peripheral Rotational Atherectomy Devices2) By Orbital Atherectomy Devices: Coronary Orbital Atherectomy Devices; Peripheral Orbital Atherectomy Devices
3) By Directional Atherectomy Devices: Coronary Directional Atherectomy Devices; Peripheral Directional Atherectomy Devices
4) By Other Products: Laser Atherectomy Devices; Excimer Laser Atherectomy Systems
Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Abbott Laboratories; Cardiovascular Systems Inc; Terumo Corporation; Avinger Inc; Straub Medical AG; AngioDynamics Inc; Rex Medical LP; Ra Medical Systems Inc; Koninklijke Philips NV; Shockwave Medical Inc; Merit Medical Systems Inc; iVascular SLU; Hawk Medical Technologies; Medinol Ltd; Cardionovum GmbH; Wellinq Medical Products; Veryan Medical; Penumbra Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Atherectomy Devices market report include:- Boston Scientific Corporation
- Medtronic plc
- Abbott Laboratories
- Cardiovascular Systems Inc
- Terumo Corporation
- Avinger Inc
- Straub Medical AG
- AngioDynamics Inc
- Rex Medical LP
- Ra Medical Systems Inc
- Koninklijke Philips NV
- Shockwave Medical Inc
- Merit Medical Systems Inc
- iVascular SLU
- Hawk Medical Technologies
- Medinol Ltd
- Cardionovum GmbH
- Wellinq Medical Products
- Veryan Medical
- Penumbra Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.11 Billion |
| Forecasted Market Value ( USD | $ 1.54 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
